1 Min Read
Dec 8 (Reuters) - Novartis Ag
* Says novartis’ ultibro breezhaler improved lung function and copd symptoms after direct switch from previous treatment Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.